These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 30265189)
1. An effective, simple and low-cost pretreatment for culture clarification in tetanus toxoid production. Avila L; Cascone O; Biscoglio M; Fingermann M Prep Biochem Biotechnol; 2018; 48(9):808-814. PubMed ID: 30265189 [TBL] [Abstract][Full Text] [Related]
2. Nitrogen-gas bubbling during the cultivation of Clostridium tetani produces a higher yield of tetanus toxin for the preparation of its toxoid. De Luca MM; Abeiro HD; Bernagozzi JA; Basualdo JA Microbiol Immunol; 1997; 41(2):161-3. PubMed ID: 9087958 [TBL] [Abstract][Full Text] [Related]
3. Pretreatments for enhancing clarification efficiency of depth filtration during production of monoclonal antibody therapeutics. Hadpe SR; Mohite V; Alva S; Rathore AS Biotechnol Prog; 2020 Sep; 36(5):e2996. PubMed ID: 32223061 [TBL] [Abstract][Full Text] [Related]
4. Effect of medium composition on the production of tetanus toxin by Clostridium tetani. Fratelli F; Siquini TJ; Prado SM; Higashi HG; Converti A; de Carvalho JC Biotechnol Prog; 2005; 21(3):756-61. PubMed ID: 15932253 [TBL] [Abstract][Full Text] [Related]
5. [Study on the effect of a biostimulant on the growth and toxigenic function of Clostridium tetani strain Copenhagen-471]. Garib FIu; Petrov VIu; Komarova EA; Sheremet'ev NN Zh Mikrobiol Epidemiol Immunobiol; 2002; (6):73-5. PubMed ID: 12506634 [TBL] [Abstract][Full Text] [Related]
6. Clarification of recombinant proteins from high cell density mammalian cell culture systems using new improved depth filters. Singh N; Pizzelli K; Romero JK; Chrostowski J; Evangelist G; Hamzik J; Soice N; Cheng KS Biotechnol Bioeng; 2013 Jul; 110(7):1964-72. PubMed ID: 23334838 [TBL] [Abstract][Full Text] [Related]
7. Fed-batch production of tetanus toxin by Clostridium tetani. Fratelli F; Siquini TJ; de Abreu ME; Higashi HG; Converti A; de Carvalho JC Biotechnol Prog; 2010; 26(1):88-92. PubMed ID: 19856382 [TBL] [Abstract][Full Text] [Related]
8. Process cost and facility considerations in the selection of primary cell culture clarification technology. Felo M; Christensen B; Higgins J Biotechnol Prog; 2013; 29(5):1239-45. PubMed ID: 23847160 [TBL] [Abstract][Full Text] [Related]
9. Clarification of vaccines: An overview of filter based technology trends and best practices. Besnard L; Fabre V; Fettig M; Gousseinov E; Kawakami Y; Laroudie N; Scanlan C; Pattnaik P Biotechnol Adv; 2016; 34(1):1-13. PubMed ID: 26657051 [TBL] [Abstract][Full Text] [Related]
10. Tetanus toxoid purification: chromatographic procedures as an alternative to ammonium-sulphate precipitation. Stojićević I; Dimitrijević L; Dovezenski N; Živković I; Petrušić V; Marinković E; Inić-Kanada A; Stojanović M J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2213-9. PubMed ID: 21741330 [TBL] [Abstract][Full Text] [Related]
11. Properties of purified tetanus toxin and toxoid. Raynaud M; Turpin A; Bizzini B Prog Immunobiol Stand; 1967; 3():244-7. PubMed ID: 4985511 [No Abstract] [Full Text] [Related]
12. The use of chitosan as a flocculant in mammalian cell culture dramatically improves clarification throughput without adversely impacting monoclonal antibody recovery. Riske F; Schroeder J; Belliveau J; Kang X; Kutzko J; Menon MK J Biotechnol; 2007 Mar; 128(4):813-23. PubMed ID: 17291617 [TBL] [Abstract][Full Text] [Related]
13. Flocculation increases the efficacy of depth filtration during the downstream processing of recombinant pharmaceutical proteins produced in tobacco. Buyel JF; Fischer R Plant Biotechnol J; 2014 Feb; 12(2):240-52. PubMed ID: 24165151 [TBL] [Abstract][Full Text] [Related]
14. A few remarks on the preparation of tetanus toxin and toxoid on casein hydrolysate medium. Lettl A; Nekvasilová K; Moravec K; Stejskal A; Petera A J Hyg Epidemiol Microbiol Immunol; 1968; 12(3):324-34. PubMed ID: 4891178 [No Abstract] [Full Text] [Related]
16. Design of a filter train for precipitate removal in monoclonal antibody downstream processing. Kandula S; Babu S; Jin M; Shukla AA Biotechnol Appl Biochem; 2009 Oct; 54(3):149-55. PubMed ID: 19656082 [TBL] [Abstract][Full Text] [Related]
17. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228 [TBL] [Abstract][Full Text] [Related]
18. Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: applicability as alternative method for the safety testing of tetanus toxoids during vaccine production. Behrensdorf-Nicol HA; Bonifas U; Hanschmann KM; Krämer B; Weißer K Vaccine; 2013 Dec; 31(52):6247-53. PubMed ID: 24156922 [TBL] [Abstract][Full Text] [Related]
19. Chitosan flocculation to aid the harvesting of the microalga Chlorella sorokiniana. Xu Y; Purton S; Baganz F Bioresour Technol; 2013 Feb; 129():296-301. PubMed ID: 23262003 [TBL] [Abstract][Full Text] [Related]
20. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid. Pirouzmand H; Khameneh B; Tafaghodi M Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]